These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15343066)

  • 1. The GABAB agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine.
    Bartoletti M; Gubellini C; Ricci F; Gaiardi M
    Behav Pharmacol; 2004 Sep; 15(5-6):397-401. PubMed ID: 15343066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baclofen blocks the development of sensitization to the locomotor stimulant effect of amphetamine.
    Bartoletti M; Gubellini C; Ricci F; Gaiardi M
    Behav Pharmacol; 2005 Nov; 16(7):553-8. PubMed ID: 16170232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of d-amphetamine-induced responses by baclofen in rats.
    Phillis BD; Ong J; White JM; Bonnielle C
    Psychopharmacology (Berl); 2001 Jan; 153(3):277-84. PubMed ID: 11271399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamine-induced locomotor sensitization in rats.
    Cedillo LN; Miranda F
    Pharmacol Rep; 2013; 65(5):1132-43. PubMed ID: 24399709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of coadministration of the GABA
    Cedillo LN; Ruíz-García RI; Jiménez JC; Miranda F
    Exp Brain Res; 2019 Jul; 237(7):1691-1697. PubMed ID: 30989246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebral baclofen administration decreases amphetamine-induced behavior and neuropeptide gene expression in the striatum.
    Zhou W; Mailloux AW; McGinty JF
    Neuropsychopharmacology; 2005 May; 30(5):880-90. PubMed ID: 15592348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic drugs inhibit amphetamine-induced distractibility in the rat.
    Agmo A; Medrano A; Garrido N; Alonso P
    Pharmacol Biochem Behav; 1997 Sep; 58(1):119-26. PubMed ID: 9264079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward.
    Halbout B; Quarta D; Valerio E; Heidbreder CA; Hutcheson DM
    Addict Biol; 2011 Jul; 16(3):416-27. PubMed ID: 21309927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization.
    Herrera AS; Casanova JP; Gatica RI; Escobar F; Fuentealba JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():1-6. PubMed ID: 23954739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAB receptor stimulation accentuates the locomotor effects of morphine in mice bred for extreme sensitivity to the stimulant effects of ethanol.
    Holstein SE; Phillips TJ
    Pharmacol Biochem Behav; 2006 Dec; 85(4):697-704. PubMed ID: 17161860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice.
    Costa FG; Frussa-Filho R; Felicio LF
    Eur J Pharmacol; 2001 Sep; 428(1):97-103. PubMed ID: 11779043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of stress and tranylcypromine on amphetamine-induced locomotor activity and GABA(B) receptor function in rat brain.
    Sands SA; Reisman SA; Enna SJ
    Life Sci; 2003 Jan; 72(9):1085-92. PubMed ID: 12495786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593.
    Fuentealba JA; Gysling K; Andrés ME
    Synapse; 2007 Sep; 61(9):771-7. PubMed ID: 17568430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
    Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
    Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of GABA(A) and GABA(B) agonists on sensitization to the locomotor stimulant effects of ethanol in DBA/2 J mice.
    Broadbent J; Harless WE
    Psychopharmacology (Berl); 1999 Jan; 141(2):197-205. PubMed ID: 9952045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors.
    David HN; Abraini JH
    Neuropharmacology; 2003 May; 44(6):717-27. PubMed ID: 12681370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine.
    Kim JH; Vezina P
    Pharmacol Biochem Behav; 2002 Sep; 73(2):333-7. PubMed ID: 12117587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GABAB agonist baclofen modifies cocaine self-administration in rats.
    Shoaib M; Swanner LS; Beyer CE; Goldberg SR; Schindler CW
    Behav Pharmacol; 1998 May; 9(3):195-206. PubMed ID: 9832934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAB receptor stimulation decreases amphetamine-induced behavior and neuropeptide gene expression in the striatum.
    Zhou W; Mailloux AW; Jung BJ; Edmunds HS; McGinty JF
    Brain Res; 2004 Apr; 1004(1-2):18-28. PubMed ID: 15033416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone and baclofen attenuate ethanol's locomotor-activating effects in preweanling Sprague-Dawley rats.
    Arias C; Mlewski EC; Molina JC; Spear NE
    Behav Neurosci; 2009 Feb; 123(1):172-80. PubMed ID: 19170442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.